IMAC Holdings, Inc. (BACK)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.19 Million USD | -67.89% |
| 2022 | 16.18 Million USD | 12.51% |
| 2021 | 14.38 Million USD | 12.08% |
| 2020 | 12.83 Million USD | -15.14% |
| 2019 | 15.12 Million USD | 125.73% |
| 2018 | 6.7 Million USD | 752.53% |
| 2017 | 786.02 Thousand USD | 5140.17% |
| 2016 | 15 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - USD | 100.0% |
| 2023 Q1 | 2.09 Million USD | -39.7% |
| 2023 Q3 | 1.56 Million USD | 16.51% |
| 2023 Q2 | 1.34 Million USD | -35.8% |
| 2023 FY | 5.19 Million USD | -67.89% |
| 2023 Q4 | -5 Million USD | -419.52% |
| 2022 Q1 | 3.89 Million USD | -10.84% |
| 2022 Q4 | 3.47 Million USD | -8.32% |
| 2022 FY | 16.18 Million USD | 12.51% |
| 2022 Q3 | 3.78 Million USD | -24.77% |
| 2022 Q2 | 5.03 Million USD | 29.22% |
| 2021 Q4 | 4.36 Million USD | 25.26% |
| 2021 Q3 | 3.48 Million USD | 0.63% |
| 2021 FY | 14.38 Million USD | 12.08% |
| 2021 Q1 | 3.06 Million USD | -11.52% |
| 2021 Q2 | 3.46 Million USD | 13.09% |
| 2020 Q4 | 3.46 Million USD | -0.42% |
| 2020 FY | 12.83 Million USD | -15.14% |
| 2020 Q3 | 3.47 Million USD | 35.19% |
| 2020 Q1 | 3.32 Million USD | -21.73% |
| 2020 Q2 | 2.57 Million USD | -22.55% |
| 2019 Q2 | 3.75 Million USD | 35.63% |
| 2019 FY | 15.12 Million USD | 125.73% |
| 2019 Q4 | 4.24 Million USD | -2.58% |
| 2019 Q3 | 4.35 Million USD | 15.95% |
| 2019 Q1 | 2.76 Million USD | -15.37% |
| 2018 Q1 | 267.85 Thousand USD | -25.17% |
| 2018 FY | 6.7 Million USD | 752.53% |
| 2018 Q4 | 3.27 Million USD | 29.59% |
| 2018 Q3 | 2.52 Million USD | 297.92% |
| 2018 Q2 | 634.7 Thousand USD | 136.96% |
| 2017 Q1 | 30.6 Thousand USD | 0.0% |
| 2017 Q2 | 90.68 Thousand USD | 196.36% |
| 2017 Q3 | 306.77 Thousand USD | 238.28% |
| 2017 FY | 786.02 Thousand USD | 5140.17% |
| 2017 Q4 | 357.96 Thousand USD | 16.69% |
| 2016 FY | 15 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 99.823% |
| Addus HomeCare Corporation | 1.05 Billion USD | 99.509% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | 97.347% |
| Amedisys, Inc. | 2.23 Billion USD | 99.768% |
| American Oncology Network, Inc. | 1.27 Billion USD | 99.594% |
| Astrana Health, Inc. | 1.38 Billion USD | 99.625% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 99.726% |
| biote Corp. | 185.36 Million USD | 97.196% |
| Cryo-Cell International, Inc. | 31.34 Million USD | 83.419% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 99.743% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 99.168% |
| The Ensign Group, Inc. | 3.72 Billion USD | 99.861% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 99.689% |
| InnovAge Holding Corp. | 763.85 Million USD | 99.32% |
| Assure Holdings Corp. | 255 Thousand USD | -1938.039% |
| The Joint Corp. | 117.69 Million USD | 95.584% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 99.508% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | 49.829% |
| ModivCare Inc. | 2.75 Billion USD | 99.811% |
| NewGenIvf Group Limited | 5.13 Million USD | -1.185% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | 58.662% |
| Option Care Health, Inc. | 4.3 Billion USD | 99.879% |
| P3 Health Partners Inc. | 1.26 Billion USD | 99.59% |
| P3 Health Partners Inc. | 1.26 Billion USD | 99.59% |
| The Pennant Group, Inc. | 544.89 Million USD | 99.046% |
| Surgery Partners, Inc. | 2.74 Billion USD | 99.811% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | 5.769% |
| Talkspace, Inc. | 150.04 Million USD | 96.536% |
| Talkspace, Inc. | 150.04 Million USD | 96.536% |
| The Oncology Institute, Inc. | 324.23 Million USD | 98.397% |
| The Oncology Institute, Inc. | 324.23 Million USD | 98.397% |